ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Heliogen Inc (QX)

Heliogen Inc (QX) (HLGN)

0.9301
-0.0499
(-5.09%)
Closed 29 April 6:00AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.9301
Bid
0.7904
Offer
1.14
Volume
3,205
0.715 Day's Range 1.00
0.6773 52 Week Range 3.90
Market Cap
Previous Close
0.98
Open
0.715
Last Trade
10
@
1
Last Trade Time
Financial Volume
US$ 2,975
VWAP
0.928137
Average Volume (3m)
7,584
Shares Outstanding
6,116,752
Dividend Yield
-
PE Ratio
-0.45
Earnings Per Share (EPS)
-21.19
Revenue
4.45M
Net Profit
-129.6M

About Heliogen Inc (QX)

Sector
Electric Services
Industry
Electric Services
Headquarters
Wilmington, Delaware, USA
Founded
-
Heliogen Inc (QX) is listed in the Electric Services sector of the OTCMarkets with ticker HLGN. The last closing price for Heliogen (QX) was US$0.98. Over the last year, Heliogen (QX) shares have traded in a share price range of US$ 0.6773 to US$ 3.90.

Heliogen (QX) currently has 6,116,752 shares in issue. The market capitalisation of Heliogen (QX) is US$5.99 million. Heliogen (QX) has a price to earnings ratio (PE ratio) of -0.45.

HLGN Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.085110.07100591720.84510.6773158000.79619063CS
40.05516.297142857140.87510.6773104010.82219386CS
12-0.0699-6.9911.250.677375840.89483005CS
26-0.3399-26.76377952761.272.39250.6773108851.33056997CS
52-0.3199-25.5921.253.90.6773105671.71727592CS
156-1.3499-59.20614035092.283.90.52132001.61424423CS
260-1.3499-59.20614035092.283.90.52132001.61424423CS

HLGN - Frequently Asked Questions (FAQ)

What is the current Heliogen (QX) share price?
The current share price of Heliogen (QX) is US$ 0.9301
How many Heliogen (QX) shares are in issue?
Heliogen (QX) has 6,116,752 shares in issue
What is the market cap of Heliogen (QX)?
The market capitalisation of Heliogen (QX) is USD 5.99M
What is the 1 year trading range for Heliogen (QX) share price?
Heliogen (QX) has traded in the range of US$ 0.6773 to US$ 3.90 during the past year
What is the PE ratio of Heliogen (QX)?
The price to earnings ratio of Heliogen (QX) is -0.45
What is the cash to sales ratio of Heliogen (QX)?
The cash to sales ratio of Heliogen (QX) is 13.2
What is the reporting currency for Heliogen (QX)?
Heliogen (QX) reports financial results in USD
What is the latest annual turnover for Heliogen (QX)?
The latest annual turnover of Heliogen (QX) is USD 4.45M
What is the latest annual profit for Heliogen (QX)?
The latest annual profit of Heliogen (QX) is USD -129.6M
What is the registered address of Heliogen (QX)?
The registered address for Heliogen (QX) is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the Heliogen (QX) website address?
The website address for Heliogen (QX) is www.heliogen.com
Which industry sector does Heliogen (QX) operate in?
Heliogen (QX) operates in the ELECTRIC SERVICES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TMPOQTempo Automation Holdings Inc (CE)
US$ 0.011
(1,099,900.00%)
115
ZUUSZEUUS Inc (CE)
US$ 1.01
(40,300.00%)
100
BYOCBeyond Commerce Inc (PK)
US$ 0.0001
(9,900.00%)
6.88M
CDIVCascadia Investments Inc (PK)
US$ 0.001
(9,900.00%)
59.04k
GBXIGBX International Group Inc (CE)
US$ 0.0001
(9,900.00%)
251
UBYHUbuyHoldings Inc (CE)
US$ 0.000001
(-99.75%)
150
SGMDSugarmade Inc (CE)
US$ 0.000001
(-99.67%)
500
CBGLCannabis Global Inc (PK)
US$ 0.000001
(-99.00%)
128.87k
TCCOTechnical Communications Corp (CE)
US$ 0.000001
(-99.00%)
200
NWTTNW Tech Capital Inc (PK)
US$ 0.000001
(-99.00%)
20.11M
CATV4Cable TV International Inc (PK)
US$ 0.0003
(-40.00%)
254.1M
DPLSDarkPulse Inc (PK)
US$ 0.0004
(0.00%)
163.44M
COWICarbonmeta Technologies Inc (CE)
US$ 0.000001
(0.00%)
158.35M
DRNKNoHo Inc (PK)
US$ 0.0004
(14.29%)
144.73M
EMEDElectroMedical Technologies Inc (PK)
US$ 0.0002
(0.00%)
140.73M

Discussion

View Full Feed
imafan imafan 5 minutes ago
Eeyore has spoken! AKA professed lying short. Real News: HUUUUGE ANNOUNCEMENTS of HUUUUGE ACCOMPLISHMENTS IMMINENT!!! WHALES LURKING!!!
HHSE
StockItOut StockItOut 5 minutes ago
Another SmartyPants/Quester lie, or you have a filing to support your assertion?
XERI
fuagf fuagf 6 minutes ago
LOL Figured that comment would grab you. 🙃 Qualification to mine would be, of course, unless they had firm numbers wrapped up with more security than Fort Knox. While fully appreciating the gravity you see in the situation, and though I've read little lately, still am guessing it's better t
glenn1919 glenn1919 6 minutes ago
CTMX..............................................a/h
CTMX
dia76ca dia76ca 6 minutes ago
"Blarcamesine and Anavex 3-71 are changing the paradigm for the treatment of neurodegenerative and neurodevelopmental diseases."
Nice summary georgejjl !
Paradigm shifts are very exciting but some folks see them before others!
The rest of this year will be pivotal.
2026 s
AVXL
Lykiri Lykiri 7 minutes ago
Actually, there’s a bit of confusion here. Under the old regulation, both positive and negative recommendations were referred to the CHM for review. However, the new regulation (effective after 3 April 2025) stipulates that only applications with serious concerns are now referred to the CHM. Therefo
NWBO
I-Glow I-Glow 7 minutes ago
And the Hindenburg report.- https://hindenburgresearch.com/mullen/.

Plus, TenKay was all over the preferred shares and the financials.

IG
MULN
boi568 boi568 8 minutes ago
Even if an ADL "odds ratio" claim could normally be considered disqualifying in lieu of a comparison of the means, it just seems to me irrelevant to the EMA here, since ADL itself is a not ready for prime time EMA endpoint in an early AD trial.
AVXL
dennisdave dennisdave 8 minutes ago
I agree with your points . However there were medicines last year which got approved by MHRA but NICE decided not to get them covered by NHS same day or so. Those companies would have been in discussions with NICE before MHRA approval . So not really sure it is absolutely comforting Ok interesting
NWBO
hedge_fun hedge_fun 8 minutes ago
That’s what I said, you’re smarter than……

the markets.

In your opinion of course!
TSLA
WarMachine WarMachine 9 minutes ago
I couldn't imagine making such a fool of myself every day on a public forum.
You don't need to imagine it. LOL
they are beyond clueless about what's really happening here
Explain, IN DETAIL, with PROOF to validate your claims, EXACTLY what is going on here. Or is it YOU who is
MONI
Uncle Monkey Uncle Monkey 9 minutes ago
wow! huge MAGA action today. FSR

hahaha
CBRF
Natural Trader Natural Trader 10 minutes ago
it does with high PT
exwannabe exwannabe 10 minutes ago
Impossible, they have to by law. They cant simply stop discussion because NWBO "might" get refusal.
I do not claim to know how the MHRA-NICE communications work.

But I do think I understand the NICE process well enough. They are at hold waiting for the evidence submission. Ever
NWBO
Truenorth2016 Truenorth2016 10 minutes ago
Any Dip Before News IMO is a Golden Opportunity Set-up!!!
CAVR
skitahoe skitahoe 11 minutes ago
There have been many bashers here saying that NICE wouldn't even speak to the company, and it would be next year or later before they would be able to treat patients with payment from the UK healthcare system. It seems like they're very wrong and the system may be ready for patients very shortly af
NWBO
dennisdave dennisdave 11 minutes ago
so it's your belief Linda dares not to disclose negative material news Ofcourse she will but I think they will probably do that when there is no more escape route IF there is bad news to report. The 10K left them no option had they prior to that received bad news so I am pretty sure they didn't rece
NWBO
manibiotech manibiotech 12 minutes ago
I agree with your points . However there were medicines last year which got approved by MHRA but NICE decided not to get them covered by NHS same day or so. Those companies would have been in discussions with NICE before MHRA approval . So not really sure it is absolutely comforting . Looks like the
NWBO
fwb fwb 12 minutes ago
You have issues,
find a woman
Let her HELP YOU get RIGHT... if you know what I mean
PLTR
I-Glow I-Glow 12 minutes ago
I believe there is a caveat to that provision as the company also has to be Deficienct in another listing requirement.

TK, can explain it much better as well as others.

IG
MULN
ddls ddls 12 minutes ago
4/28/25, Buy: 525,000, Neutral: 4,076,000, Sell: 11,275,500

One last day buy ask slap trade to make this junk look good.
BIEL
archilles archilles 12 minutes ago
Isn’t there a newly graduated law student recently passed the bar exam lawyer who will take on this case for experience for small pro bono fees. This should be a relatively easy to identify the bad guys and the victims. What we have here are the victim shareholders, who got ripped off, versus the
ENZC